ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.

ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Collins, R, Peto, R, Parish, S, Sleight, P
التنسيق: Journal article
اللغة:English
منشور في: 1993

مواد مشابهة